HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV-Reference-Cited by-同舟云学术

HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV

Published:2014-05-27 Issue:1 Volume:60 Page:98-105
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Kanwal Fasiha¹²,Kramer Jennifer R.¹³,Ilyas Jawad²,Duan Zhigang³,El-Serag Hashem B.¹²

Affiliation:

1. Clinical Epidemiology and Outcomes Program, Houston VA Health Services Research and Development Center of Excellence, Center for Innovations in Quality, Effectiveness, and Safety (IQuESt); Michael E. DeBakey Veterans Affairs Medical Center; Houston TX

2. Section of Gastroenterology and Hepatology, Department of Medicine; Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center; Houston TX

3. Section of Health Services Research, Department of Medicine; Baylor College of Medicine; Houston TX

Publisher

Wiley

Subject

Hepatology

Reference22 articles.

1. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002;Armstrong;Ann Intern Med,2006

2. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression;Davis;Gastroenterology,2010

3. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis;Kanwal;Clin Gastroenterol Hepatol,2010

4. Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors;Missiha;Gastroenterology,2008

5. Natural history of chronic hepatitis C;Seeff;Hepatology,2002

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease;Viruses;2024-08-03

2. The prognosis associated factors of chronic hepatitis C patients and a case report of resistance-associated substitutions to sofosbuvir-velpatavir treatment;2024-07-02

3. Efficacy, safety, and quality of life profile of Genotype-3 Chronic Hepatitis-C Pakistani patients receiving ledipasvir plus sofosbuvir treatment;Pakistan Journal of Medical Sciences;2024-06-22

4. Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments—An Overview;Biomolecules;2024-06-04

5. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review;Microorganisms;2024-05-21